Table 2 Pathways of circRNAs degradation.
Degradation pathways | Location | Interacting molecule | Related disease | Reference number |
|---|---|---|---|---|
Endonuclease-mediated degradation | Nuclear/cytoplasm | RNase H1, Template DNA strand / RNase L, PKR | Systemic lupus erythematosus | |
Ago2-mediated degradation | Nuclear | miRNA, Ago2 | Chronic inflammatory pain | |
GW182-mediated degradation | \ | GW182 | \ | |
m6A modification-mediated degradation | Cytoplasm | YTHDF2, HRSP12, RNase-P/MRP | Hepatocellular carcinoma | |
Structure-mediated degradation | Cytoplasm | G3BP1, UPF1 | \ | |
TMAO-mediated degradation | Cytoplasm | TMAO | Dysbacteriosis in gut | |
Exosome-mediated degradation | Extracellular space | exosomes/ microvesicles | \ |